Your browser doesn't support javascript.
loading
Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose.
Jilg, Stefanie; Hauch, Richard T; Kauschinger, Johanna; Buschhorn, Lars; Odinius, Timo O; Dill, Veronika; Müller-Thomas, Catharina; Herold, Tobias; Prodinger, Peter M; Schmidt, Burkhard; Hempel, Dirk; Bassermann, Florian; Peschel, Christian; Götze, Katharina S; Höckendorf, Ulrike; Haferlach, Torsten; Jost, Philipp J.
Afiliação
  • Jilg S; Medical Department III for Hematology and Oncology, Klinikum rechts der Isar, Technische Universität München, Ismaninger Strasse 22, 81675 Munich, Germany.
  • Hauch RT; Medical Department III for Hematology and Oncology, Klinikum rechts der Isar, Technische Universität München, Ismaninger Strasse 22, 81675 Munich, Germany.
  • Kauschinger J; Medical Department III for Hematology and Oncology, Klinikum rechts der Isar, Technische Universität München, Ismaninger Strasse 22, 81675 Munich, Germany.
  • Buschhorn L; Medical Department III for Hematology and Oncology, Klinikum rechts der Isar, Technische Universität München, Ismaninger Strasse 22, 81675 Munich, Germany.
  • Odinius TO; Medical Department III for Hematology and Oncology, Klinikum rechts der Isar, Technische Universität München, Ismaninger Strasse 22, 81675 Munich, Germany.
  • Dill V; Medical Department III for Hematology and Oncology, Klinikum rechts der Isar, Technische Universität München, Ismaninger Strasse 22, 81675 Munich, Germany.
  • Müller-Thomas C; Medical Department III for Hematology and Oncology, Klinikum rechts der Isar, Technische Universität München, Ismaninger Strasse 22, 81675 Munich, Germany.
  • Herold T; 2Department of Internal Medicine 3, University Hospital Grosshadern, Ludwig-Maximilians-Universität (LMU), 81377 Munich, Germany.
  • Prodinger PM; Department of Orthopedic Surgery, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
  • Schmidt B; Gemeinschaftspraxis Hämato-Onkologie Pasing, Munich, Germany.
  • Hempel D; Onkologisches Zentrum Donauwörth, Donauwörth, Germany.
  • Bassermann F; Medical Department III for Hematology and Oncology, Klinikum rechts der Isar, Technische Universität München, Ismaninger Strasse 22, 81675 Munich, Germany.
  • Peschel C; 6German Consortium for Translational Cancer Research (DKTK) of the German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Götze KS; Medical Department III for Hematology and Oncology, Klinikum rechts der Isar, Technische Universität München, Ismaninger Strasse 22, 81675 Munich, Germany.
  • Höckendorf U; 6German Consortium for Translational Cancer Research (DKTK) of the German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Haferlach T; Medical Department III for Hematology and Oncology, Klinikum rechts der Isar, Technische Universität München, Ismaninger Strasse 22, 81675 Munich, Germany.
  • Jost PJ; 6German Consortium for Translational Cancer Research (DKTK) of the German Cancer Research Center (DKFZ), Heidelberg, Germany.
Exp Hematol Oncol ; 8: 9, 2019.
Article em En | MEDLINE | ID: mdl-31016067
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article